SPONSOR

Peking University Third Hospital

Total Trials

Recruiting

Phases

Phase 2

Conditions studied: Knee Injuries and Disorders Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Tumor Thrombus Prognosis Prognostic Cancer Model Real World Study Observational Study Femoroacetabular Impingement Syndrome Glioblastoma (GBM)

Peking University Third Hospital is a clinical research sponsor with 18 registered studies on ClinicalTrials.gov, of which 18 are actively recruiting participants. Research covers conditions including Knee Injuries and Disorders, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Peking University Third Hospital

How many clinical trials has Peking University Third Hospital sponsored?

ClinicalMetric currently tracks 18 clinical trials sponsored by Peking University Third Hospital, of which 18 are actively recruiting participants. These trials cover conditions including Knee Injuries and Disorders, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Peking University Third Hospital research focus on?

Peking University Third Hospital clinical trials span Knee Injuries and Disorders, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Tumor Thrombus, Prognosis, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Peking University Third Hospital clinical trial?

To participate in a Peking University Third Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University Third Hospital trials with current recruitment status updated daily.

Peking University Third Hospital

Frequently Asked Questions — Peking University Third Hospital

Clinical Trials by Peking University Third Hospital

Evaluation of Long-term Isokinetic Training of Knee Joint

Validation of RCC Predicting Model With Emulated-target Trial

Comparison of Surgery With Prehabilitation, Direct Surgery and Rehabilitation for Patients With Femoroacetabular Impingement

Allogeneic γδT Cells in Glioblastoma

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors

Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth

Trigger Timing in Ovarian Stimulations

Effect of Pre-existing Adjacent Segment Degeneration on Long-term Effectiveness After Lumbar Fusion Surgery

PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer

The Cohort Construction Project of Peking University Third Hospital

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Establishment of Clinical Prediction Model for Postoperative Symptomatic Spinal Epidural Hematoma

Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison

Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes

Screening of Malignant Hyperthermia Susceptible Individuals

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale